|
|
|
|
|
By Ray Dogum, chief editor, Drug Discovery Online | Understanding the full scope of the life science industry has never been more critical. Ray Dogum, Chief Editor of Drug Discovery Online, joins the Life Science Connect Editors’ Roundtable on a special episode of Better Biopharma podcast. | |
|
|
|
By Andy Tang, Partner, Draper Associates | VCs are looking to invest in cheaper, generic LLMs rather than expensive, customized LLMs in drug discovery. | |
|
|
|
|
| Antibody-Drug Conjugates – Catalysts For Chemistry | White Paper | Curia | Explore the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development. |
|
|
|
|
| Altasciences' State-Of-The-Art Research Facilities | Product | Altasciences | With over 585,000-sq.-ft. of purpose-built space, our preclinical facilities across North America are designed to support your drug development journey, from early discovery to IND/NDA submission. |
|
|
|
|
|
|
|